You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PET agent

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Cleveland ([11C]MeDAS)

Not yet recruiting
  • Healthy
  • Cleveland, Ohio
    Cleveland Clinic
Feb 3, 2022

Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

Not yet recruiting
  • Marginal Zone Lymphoma
  • (no location specified)
Nov 6, 2023

Ischemic Heart Disease (IHD) Trial in Tianjin (XTR003)

Completed
  • Ischemic Heart Disease (IHD)
  • Tianjin, Tianjin, China
    TEDA International Cardiovascular Hospital
May 23, 2023

Malignant Brain Tumors Trial in Berkel en Rodenrijs (procedure, device, other)

Recruiting
  • Malignant Brain Tumors
  • intra-arterial injection
  • +2 more
  • Berkel en Rodenrijs, Zuid Holland, Netherlands
    Laurens Groenendijk
Apr 3, 2023

Prostate Cancer Trial in Bala-Cynwyd (rhPSMA-7.3 (18F))

Not yet recruiting
  • Prostate Cancer
  • rhPSMA-7.3 (18F)
  • Bala-Cynwyd, Pennsylvania
    MidLantic Urology
Mar 22, 2023

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in San Francisco (drug, biological, procedure)

Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • San Francisco, California
    University of California, San Francisco
Mar 29, 2022

Head Neck Cancer Trial in New York ([18F]- PARPi, PET/CT Scans)

Active, not recruiting
  • Head and Neck Cancer
  • [18F]- PARPi
  • PET/CT Scans
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 14, 2021

Prostate Cancer, Recurrent Prostate Cancer Trial in Tampa (F-DCFPyL Injection, PSMA PET)

Recruiting
  • Prostate Cancer
  • Recurrent Prostate Cancer
  • F-DCFPyL Injection
  • PSMA PET
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Using TSPO

Recruiting
  • Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection
  • PET Tracer
  • +2 more
  • New York, New York
    NYU Langone Health
Nov 7, 2022

Metastatic Cancer, Carcinoma, Adenocarcinoma Trial in Cleveland (18F-Clofarabine)

Recruiting
  • Metastatic Cancer
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
May 11, 2022

Cytoreductive Surgery, Grade 3 Endometrial Endometrioid Adenocarcinoma, High Grade Serous Carcinoma Trial in Boston (PET/MRI

Not yet recruiting
  • Cytoreductive Surgery
  • +4 more
  • PET/MRI with radiotracer ([18F]- fluorodeoxyglucose) and a gadolinium-based contrast agent
  • Boston, Massachusetts
    Massachusetts General Hospital
May 21, 2022

Prostate Cancer Trial in New York (18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent, PET MRI Imaging)

Not yet recruiting
  • Prostate Cancer
  • 18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent
  • PET MRI Imaging
  • New York, New York
    Smilow Comprehensive Prostate Cancer Center
Jan 9, 2023

Diagnostic Agent Adverse Reaction, Radiation Exposure Trial in New Haven (18F-LY3950321, PET Scan)

Recruiting
  • Diagnostic Agent Adverse Reaction
  • Radiation Exposure
  • New Haven, Connecticut
    Invicro, LLC
Mar 20, 2023

Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte (biological, drug, procedure, other)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • +2 more
  • Daratumumab
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Solid Tumor Trial in Suzhou (68Ga-NODAGA-SNA006)

Recruiting
  • Solid Tumor
  • 68Ga-NODAGA-SNA006
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 8, 2022

Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)

Not yet recruiting
  • Extramedullary Myeloma
  • Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Dec 18, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • San Francisco, California
    University of California San Francisco
Dec 19, 2022

Metastatic Cancer, Unresectable Malignant Tumor Trial in Groningen (Anti-CD8 PET imaging agent)

Recruiting
  • Metastatic Cancer
  • Unresectable Malignant Neoplasm
  • Anti-CD8 PET imaging agent
  • Groningen, Netherlands
    University Medical Center Groningen
Mar 1, 2022

An Imaging Agent With Positron Emission Tomography/Magnetic

Recruiting
  • Recurrent Soft Tissue Sarcoma
  • +2 more
  • Fluorodopa F 18
  • +4 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Multiple Myeloma Trial in Duarte (Biospecimen Collection, Bone Marrow Aspiration, Computed Tomography)

Recruiting
  • Multiple Myeloma
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Sep 21, 2023

Positron-Emission Tomography, Metastatic Solid Tumors Trial in United States (8?Zr-Df-IAB22M2C)

Completed
  • Positron-Emission Tomography
  • Metastatic Solid Tumors
  • Birmingham, Alabama
  • +14 more
Nov 15, 2022

Neuroendocrine Carcinoma Trial in Los Angeles (68Ga-DOTATATE)

Completed
  • Neuroendocrine Carcinoma
  • Los Angeles, California
    University of California Los Angeles, Nuclear Medicine Clinic of
May 12, 2021

Melanoma, Merkel Cell Carcinoma, Unspecified, Renal Cell Carcinoma Trial in Australia, Netherlands, United States

Recruiting
  • Melanoma
  • +3 more
  • 89Zr-Df-Crefmirlimab
  • Little Rock, Arkansas
  • +7 more
Jul 11, 2022

Gastro-Enteropancreatic Neuroendocrine Tumor Trial in Austria, Denmark, United States (Satoreotide trizoxetan 5-20µg,

Completed
Has Results
  • Gastro-Enteropancreatic Neuroendocrine Tumor
  • Satoreotide trizoxetan 5-20μg
  • Satoreotide trizoxetan 30-45μg
  • Los Angeles, California
  • +4 more
Jan 8, 2021

Breast Cancer Trial in Innsbruck (Satoreotide trizoxetan)

Terminated
Has Results
  • Breast Cancer
  • Satoreotide trizoxetan
  • Innsbruck, Austria
    Medical University Innsbruck
Aug 18, 2020